Ratings by Lucid Capital Markets
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/2/2026 | Alex Nowak | Xtant Medical | XTNT | New Coverage | Buy (N/A) |
1.00 (N/A) |
0.37 (0.42) |
13.51% | Details |
| 9/1/2026 | Elemer Piros | Nuvectis Pharma | NVCT | New Coverage | Buy (N/A) |
40.00 (N/A) |
22.73 (23.52) |
3.48% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 171 more... | |||||||||
